Why are we issuing shares now? Medinice in PAP Biznes
September 27, 2024
Medinice wants to raise funds to complete clinical trials and secure operations until the sale of at least one of its leading projects is finalized. To this end, it plans to issue up to 1.2 million shares. The decision in this matter will be made by the Extraordinary General Meeting of Shareholders (EGM), company president Sanjeev Choudhary told PAP Biznes.
The CEO stated that there is strong interest in the company, both among private investors and professional institutional entities, which should have a positive impact on securing financing.
We Care About Your Privacy
Medinice S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience.
Privacy Policy